Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.37 |
| ▸ | TBK1 | Q9UHD2 | 7/20 | 0.36 |
| ▸ | JAK2 | O60674 | 3/20 | 0.36 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.34 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.34 |
| ▸ | PAK1 | Q13153 | 4/20 | 0.34 |
| ▸ | JAK1 | P23458 | 1/20 | 0.33 |
| ▸ | TYK2 | P29597 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962809 | 0.88 | EHMT2 (0.37) | EHMT2TBK1JAK2PKMYT1ALK | |
| SCHEMBL30962675 | 0.88 | EHMT2 (0.39) | EHMT2TBK1JAK2ALKPAK1 | |
| SCHEMBL30962632 | 0.82 | WEE1 (0.43) | EHMT2TBK1JAK2PKMYT1ALK | |
| SCHEMBL30962719 | 0.80 | PTK2 (0.40) | TBK1JAK2PKMYT1PTK2JAK3 | |
| SCHEMBL30962917 | 0.80 | WEE1 (0.40) | EHMT2TBK1JAK2ALKWEE1 | |
| SCHEMBL30962572 | 0.79 | WEE1 (0.41) | EHMT2TBK1JAK2PKMYT1ALK | |
| SCHEMBL30962797 | 0.78 | WEE1 (0.47) | EHMT2TBK1JAK2ALKPTK2 | |
| SCHEMBL30962912 | 0.78 | TBK1 (0.41) | EHMT2TBK1JAK2PKMYT1ALK | |
| SCHEMBL30962777 | 0.78 | WEE1 (0.46) | EHMT2TBK1JAK2ALKPTK2 | |
| SCHEMBL30962727 | 0.77 | ALK (0.45) | EHMT2ALKPTK2PAK1WEE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024145505-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | ACRIVON THERAPEUTICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |